HK Stock Market Move | DIAGENS-B(02526) rose by more than 22% to hit a new high. Its core product AI AutoVision has won the first three-category certificate in the medical imaging field.

DIAGENS-B (02526) saw a rise of over 22% in the morning session, reaching a high of 428 Hong Kong dollars, once again hitting a new record high. As of the time of writing, it has risen by 17.43%, reaching 411 Hong Kong dollars, with a trading volume of 29,213,900 Hong Kong dollars. On the news front, De Shi announced that its self-developed AI AutoVision chromosomal karyotype diagnostic software has officially obtained the National Medical Products Administration's Class III medical device registration certificate. The approved indications for this certificate cover chromosomal karyotype analysis for prenatal diagnosis of birth defects using amniotic fluid samples, as well as chromosomal karyotype analysis for assisted reproductive purposes using peripheral blood samples. According to the Board of Directors and the information currently available to the company, this registration certificate is the first in the world for chromosomal karyotype analysis with abnormal detection capabilities and reaching Level III for a Class III medical device. It is also the first medical device registration certificate obtained based on large model technology. The Board of Directors believes that the acquisition of this certificate reflects the regulatory recognition of the safety, effectiveness, and clinical value of iMedImage medical image large model technology in medical devices.